In vivo selection of tumor-specific antibodies
In vivo selection of tumor-specific antibodies |
|
https://doi.org/10.18632/oncotarget.1407
David Sánchez-Martín,
Laura Sanz,
Erkki Ruoslahti,
and Luis Alvarez-Vallina
|
| 1547 |
Estrogen response in luminal breast cancer
Estrogen response in luminal breast cancer |
|
https://doi.org/10.18632/oncotarget.1354
Leticia B A Rangel,
and Tim Hui-Ming Huang
|
| 1548-1549 |
IκBα beyond the NF-kB dogma
IκBα beyond the NF-kB dogma |
|
https://doi.org/10.18632/oncotarget.1325
María Carmen Mulero,
Anna Bigas,
and Lluís Espinosa
|
| 1550-1551 |
Cytokine-induced ‘bystander’ senescence in DDR and immuno-surveillance
Cytokine-induced ‘bystander’ senescence in DDR and immuno-surveillance |
|
https://doi.org/10.18632/oncotarget.1487
Zdenek Hodny,
Sona Hubackova,
and Jiri Bartek
|
| 1552-1553 |
Ribosomes: the future of targeted therapies?
Ribosomes: the future of targeted therapies? |
|
https://doi.org/10.18632/oncotarget.1511
Virginie Marcel,
Frédéric Catez,
and Jean-Jacques Diaz
|
| 1554-1555 |
Lysine-specific modifications of p53: a matter of life and death?
Lysine-specific modifications of p53: a matter of life and death? |
|
https://doi.org/10.18632/oncotarget.1436
Diana Marouco,
Alexander V Garabadgiu,
Gerry Melino,
and Nick A Barlev
|
| 1556-1571 |
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy |
|
https://doi.org/10.18632/oncotarget.1157
Laura Bonanno,
Carlota Costa,
Margarita Majem,
Jose Javier Sanchez,
Ana Gimenez-Capitan,
Ignacio Rodriguez,
Alain Vergenegre,
Bartomeu Massuti,
Adolfo Favaretto,
Massimo Rugge,
Cinta Pallares,
Miquel Taron,
and Rafael Rosell
|
| 1572-1581 |
High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients
High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients |
|
https://doi.org/10.18632/oncotarget.1050
Marc Delord,
Philippe Rousselot,
Jean-Michel Cayuela,
François Sigaux,
Joëlle Guilhot,
Claude Preudhomme,
François Guilhot,
Pascale Loiseau,
Emmanuel Raffoux,
Daniela Geromin,
Emmanuelle Genin,
Fabien Calvo,
and Heriberto Bruzzoni-Giovanelli
|
| 1582-1591 |
Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer
Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer |
|
https://doi.org/10.18632/oncotarget.1148
Alexandra Canonici,
Merel Gijsen,
Maeve Mullooly,
Ruth Bennett,
Noujoude Bouguern,
Kasper Pedersen,
Neil A O’Brien,
Ioannis Roxanis,
Ji-Liang Li,
Esther Bridge,
Richard Finn,
Dennis Slamon,
Patricia McGowan,
Michael J. Duffy,
Norma O’Donovan,
John Crown,
and Anthony Kong
|
| 1592-1605 |
Small-molecule targeting of translation initiation for cancer therapy
Small-molecule targeting of translation initiation for cancer therapy |
|
https://doi.org/10.18632/oncotarget.1186
Bertal H. Aktas,
Yuan Qiao,
Esra Ozdelen,
Roland Schubert,
Sema Sevinc,
Fred Harbinski,
Luciano Grubissich,
Samuel Singer,
and Jose A. Halperin
|
| 1606-1617 |
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.1221
Catia Giovannini,
Michele Baglioni,
Marco Baron Toaldo,
Cristiano Ventrucci,
Stefania D'Adamo,
Mario Cipone,
Pasquale Chieco,
Laura Gramantieri,
and Luigi Bolondi
|
| 1618-1631 |
The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth
The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth |
|
https://doi.org/10.18632/oncotarget.1365
Elena Kurenova,
Jianqun Liao,
Di-Hua He,
Darrell Hunt,
Michael Yemma,
Wiam Bshara,
Mukund Seshadri,
and William G Cance
|
| 1632-1646 |
The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design
The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design |
|
https://doi.org/10.18632/oncotarget.1255
Sylvain Couty,
Isaac M. Westwood,
Andrew Kalusa,
Celine Cano,
Jon Travers,
Kathy Boxall,
Chiau Ling Chow,
Sam Burns,
Jessica Schmitt,
Lisa Pickard,
Caterina Barillari,
P. Craig McAndrew,
Paul A. Clarke,
Spiros Linardopoulos,
Roger J. Griffin,
G. Wynne Aherne,
Florence I. Raynaud,
Paul Workman,
Keith Jones,
and Rob L.M. van Montfort
|
| 1647-1661 |
HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma
HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma |
|
https://doi.org/10.18632/oncotarget.1232
Bryce P Portier,
Eugen C. Minca,
Zhen Wang,
Christopher Lanigan,
Aaron M. Gruver,
Erinn Downs-Kelly,
G. Thomas Budd,
and Raymond R. Tubbs
|
| 1662-1672 |
Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer
Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer |
|
https://doi.org/10.18632/oncotarget.1237
Tiago Baptista,
Inês Graça,
Elsa J Sousa,
Ana I Oliveira,
Natália R Costa,
Pedro Costa-Pinheiro,
Francisco Amado,
Rui Henrique,
and Carmen Jeronimo
|
| 1673-1685 |
Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration
Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration |
|
https://doi.org/10.18632/oncotarget.1265
Sandra Cascio,
Adam M Farkas,
Rebecca P Hughey,
and Olivera J Finn
|
| 1686-1697 |
Lung cancer tumorigenicity and drug resistance are maintained through ALDHhi CD44hi tumor initiating cells
Lung cancer tumorigenicity and drug resistance are maintained through ALDHhi CD44hi tumor initiating cells |
|
https://doi.org/10.18632/oncotarget.1246
Jing Liu,
Zhijie Xiao,
Sunny Kit-Man Wong,
Vicky Pui-Chi Tin,
Ka-Yan Ho,
Junwen Wang,
Mai-Har Sham,
and Maria Pik Wong
|
| 1698-1711 |
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.1280
Riccardo Masetti,
Marco Togni,
Annalisa Astolfi,
Martina Pigazzi,
Elena Manara,
Valentina Indio,
Carmelo Rizzari,
Sergio Rutella,
Giuseppe Basso,
Andrea Pession,
and Franco Locatelli
|
| 1712-1720 |
Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma
Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma |
|
https://doi.org/10.18632/oncotarget.1379
Andrea Treszl,
Zita Steiber,
Andrew V Schally,
Norman L Block,
Balazs Dezso,
Gabor Olah,
Bernadett Rozsa,
Klara Fodor,
Armin Buglyo,
Janos Gardi,
Andras Berta,
and Gabor Halmos
|
| 1721-1728 |
Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine.
Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine. |
|
https://doi.org/10.18632/oncotarget.1412
Sevin Turcan,
Armida WM Fabius,
Alexandra Borodovsky,
Alicia Pedraza,
Cameron Brennan,
Jason Huse,
Agnes Viale,
Gregory J Riggins,
and Timothy A Chan
|
| 1729-1736 |
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft |
|
https://doi.org/10.18632/oncotarget.1408
Alexandra Borodovsky,
Vafi Salmasi,
Sevin Turcan,
Armida W. M. Fabius,
Gilson Baia,
Charles G Eberhart,
Jon D. Weingart,
Gary L Gallia,
Stephen B Baylin,
Timothy A Chan,
and Gregory J Riggins
|
| 1737-1747 |
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations |
|
https://doi.org/10.18632/oncotarget.1292
Roxana S Redis,
Anieta M Siewerts,
Maxime P Look,
Oana Tudoran,
Cristina Ivan,
Riccardo Spizzo,
Xinna Zhang,
Vanja de Weerd,
Masayoshi Shimizu,
Hui Ling,
Rares Buiga,
Victor Pop,
Alexandru Irimie,
Riccardo Fodde,
Isabella Bedrosian,
John WM Martens,
John A Foekens,
Ioana Berindan-Neagoe,
and George A Calin
|
| 1748-1762 |
Identification of novel small molecule inhibitors of centrosome clustering in cancer cells
Identification of novel small molecule inhibitors of centrosome clustering in cancer cells |
|
https://doi.org/10.18632/oncotarget.1198
Eiko Kawamura,
Andrew B. Fielding,
Nagarajan Kannan,
Aruna Balgi,
Connie J. Eaves,
Michel Roberge,
and Shoukat Dedhar
|
| 1763-1776 |
Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine
Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine |
|
https://doi.org/10.18632/oncotarget.1295
Duane H. Hamilton,
Mary T. Litzinger,
Alessandra Jales,
Bruce Huang,
Romaine I. Fernando,
James W. Hodge,
Andressa Ardiani,
David Apelian,
Jeffrey Schlom,
and Claudia Palena
|
| 1777-1790 |
Upregulation of adenylate cyclase 3 (ADCY3) increases the tumorigenic potential of cells by activating the CREB pathway
Upregulation of adenylate cyclase 3 (ADCY3) increases the tumorigenic potential of cells by activating the CREB pathway |
|
https://doi.org/10.18632/oncotarget.1324
Seung-Hyun Hong,
Sung-Ho Goh,
Sang-Jin Lee,
Jung-Ah Hwang,
Jieun Lee,
Il-Ju Choi,
Hyehyun Seo,
Jong-Hoon Park,
Hiromu Suzuki,
Eiichiro Yamamoto,
In-Hoo Kim,
Jin Sook Jeong,
Mi Ha Ju,
Dong-Hee Lee,
and Yeon-Su Lee
|
| 1791-1803 |
Cholesterol-induced mammary tumorigenesis is enhanced by adiponectin deficiency: role of LDL receptor upregulation
Cholesterol-induced mammary tumorigenesis is enhanced by adiponectin deficiency: role of LDL receptor upregulation |
|
https://doi.org/10.18632/oncotarget.1364
Jing Liu,
Aimin Xu,
Karen Siu-Ling Lam,
Nai-Sum Wong,
Jie Chen,
Peter R R Shepherd,
and Yu Wang
|
| 1804-1818 |
Identification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation
Identification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation |
|
https://doi.org/10.18632/oncotarget.1312
Xiaoping Wu,
Huixian Huang,
Cong Wang,
Shaoqiang Lin,
Yadong Huang,
Yi Wang,
Guang Liang,
Qiuxia Yan,
Jian Xiao,
Jianzhang Wu,
Yongguang Yang,
and Xiaokun Li
|
| 1819-1828 |
Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector
Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector |
|
https://doi.org/10.18632/oncotarget.1397
Franco Venanzi,
Victor Shifrin,
Michael Y. Sherman,
Vladimir Gabai,
Oleg Kisilev,
Andrey Komissarov,
Mikhail Grudinin,
Maria Shartakova,
Ekaterina Romanovskaya-Romanko,
Yuri Kudryavets,
Natalya Bezdenezhnykh,
Oleksandra Lykhova,
Nadiia Semesyuk,
Antonio Concetti,
Anatoly Tsyb,
Marina Filimonova,
Victoria Makarchuk,
Raisa Yakubovsky,
Andrey Chursov,
Vita Shcherbinina,
and Alexander Shneider
|
| 1829-1835 |
The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis
The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis |
|
https://doi.org/10.18632/oncotarget.1282
Cheryl McFarlane,
Suzanne McFarlane,
Ian Paul,
Kenneth Arthur,
Michael Scheaff,
Keith Kerr,
Michael Stevenson,
Dean A Fennell,
and James A Johnston
|
| 1836-1843 |
PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis
PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis |
|
https://doi.org/10.18632/oncotarget.1300
Zeyad D Nassar,
Hyeongsun Moon,
Tam Duong,
LiQi Neo,
Michelle M Hill,
Mathias Francois,
Robert G Parton,
and Marie-Odile Parat
|
| 1844-1855 |
Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA
Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA |
|
https://doi.org/10.18632/oncotarget.1486
Luis A. Diaz, Jr,
Mark Sausen,
George A. Fisher,
and Victor E. Velculescu
|
| 1856-1857 |
